Manabu Kawada
Numazu Bio-Medical Research Institute
Microbial Chemistry Research Center
Shizuoka
Japan
Name/email consistency: high
- NBRI17671, a new antitumor compound, produced by Acremonium sp. CR17671. Kawada, M., Usami, I., Someno, T., Watanabe, T., Abe, H., Inoue, H., Ohba, S., Masuda, T., Tabata, Y., Yamaguchi, S., Ikeda, D. J. Antibiot. (2010)
- Leucinostatin A inhibits prostate cancer growth through reduction of insulin-like growth factor-I expression in prostate stromal cells. Kawada, M., Inoue, H., Ohba, S., Masuda, T., Momose, I., Ikeda, D. Int. J. Cancer (2010)
- NBRI16716A, a new antitumor compound against human prostate cancer cells, produced by Perisporiopsis melioloides Mer-f16716. Kawada, M., Someno, T., Inoue, H., Ohba, S., Masuda, T., Kato, T., Ikeda, D. J. Antibiot. (2010)
- New atpenins, NBRI23477 A and B, inhibit the growth of human prostate cancer cells. Kawada, M., Momose, I., Someno, T., Tsujiuchi, G., Ikeda, D. J. Antibiot. (2009)
- Phthoxazolin A inhibits prostate cancer growth by modulating tumor-stromal cell interactions. Kawada, M., Inoue, H., Usami, I., Ikeda, D. Cancer Sci. (2009)
- Transforming growth factor-beta1 modulates tumor-stromal cell interactions of prostate cancer through insulin-like growth factor-I. Kawada, M., Inoue, H., Arakawa, M., Ikeda, D. Anticancer Res. (2008)
- Highly tumorigenic human androgen receptor-positive prostate cancer cells overexpress angiogenin. Kawada, M., Inoue, H., Arakawa, M., Takamoto, K., Masuda, T., Ikeda, D. Cancer Sci. (2007)
- Establishment of a highly tumorigenic LNCaP cell line having inflammatory cytokine resistance. Kawada, M., Inoue, H., Usami, I., Takamoto, K., Masuda, T., Yamazaki, Y., Ikeda, D. Cancer Lett. (2006)
- Insulin-like growth factor I secreted from prostate stromal cells mediates tumor-stromal cell interactions of prostate cancer. Kawada, M., Inoue, H., Masuda, T., Ikeda, D. Cancer Res. (2006)
